Literature DB >> 30766008

Pharmaceutical Approval Update.

Michele B Kaufman.   

Abstract

Arikayce (amikacin liposome inhalation suspension) for Mycobacterium avium complex lung disease; Xofluza (baloxavir marboxil) for acute uncomplicated influenza; and Nuzyra (omadacycline) for community-acquired bacterial pneumonia and/or acute bacterial skin and skin structure infections.

Entities:  

Year:  2019        PMID: 30766008      PMCID: PMC6355053     

Source DB:  PubMed          Journal:  P T        ISSN: 1052-1372


  1 in total

1.  Protein Disulfide Isomerase A3 Regulates Influenza Neuraminidase Activity and Influenza Burden in the Lung.

Authors:  Nicolas Chamberlain; Mona Ruban; Zoe F Mark; Sierra R Bruno; Amit Kumar; Ravishankar Chandrasekaran; Dhemerson Souza De Lima; Danielle Antos; Emily M Nakada; John F Alcorn; Vikas Anathy
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.